We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$445M
AUM Growth
+$6.22M
Cap. Flow
+$4.93M
Cap. Flow %
1.11%
Top 10 Hldgs %
17.39%
Holding
285
New
23
Increased
106
Reduced
62
Closed
22

Top Buys

1
HON icon
Honeywell
HON
+$2.81M
2
RTX icon
RTX Corp
RTX
+$2.68M
3
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$1.79M
4
PH icon
Parker-Hannifin
PH
+$1.6M
5
KLAC icon
KLA
KLAC
+$1.21M

Top Sells

1
KS
KapStone Paper and Pack Corp.
KS
+$4.63M
2
MO icon
Altria Group
MO
+$2.29M
3
PG icon
Procter & Gamble
PG
+$2.11M
4
PM icon
Philip Morris
PM
+$1.94M
5
MON
Monsanto Co
MON
+$1.32M

Sector Composition

1 Industrials 17.84%
2 Healthcare 15.87%
3 Technology 15.47%
4 Materials 7.53%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QLYS icon
1
Qualys
QLYS
$5.61B
$10.4M 2.33%
122,803
-14,464
-11% -$1.16M
TIF
2
DELISTED
Tiffany & Co.
TIF
$9.54M 2.14%
72,500
-2,500
-3% -$285K
NBIX icon
3
Neurocrine Biosciences
NBIX
$17.2B
$8.83M 1.98%
89,884
+10,728
+14% +$960K
HDP
4
DELISTED
Hortonworks, Inc.
HDP
$8.01M 1.8%
439,584
-21,119
-5% -$380K
PFPT
5
DELISTED
Proofpoint, Inc.
PFPT
$7.5M 1.68%
65,055
+180
+0.3% +$21.9K
CW icon
6
Curtiss-Wright
CW
$26.1B
$7.2M 1.62%
60,457
+1,210
+2% +$158K
PYPL icon
7
PayPal
PYPL
$49.9B
$7.04M 1.58%
84,577
-2,515
-3% -$200K
DAR icon
8
Darling Ingredients
DAR
$10B
$6.52M 1.46%
327,829
-130
-0% -$2.35K
TMO icon
9
Thermo Fisher Scientific
TMO
$198B
$6.25M 1.4%
30,160
+127
+0.4% +$27K
ROK icon
10
Rockwell Automation
ROK
$51.4B
$6.19M 1.39%
37,246
-373
-1% -$64.8K
PWR icon
11
Quanta Services
PWR
$94.3B
$6.11M 1.37%
182,980
+3,886
+2% +$136K
FMC icon
12
FMC
FMC
$1.4B
$6.07M 1.36%
78,500
+1,231
+2% +$91.4K
LH icon
13
Labcorp
LH
$23.2B
$5.85M 1.31%
37,921
+983
+3% +$148K
ANET icon
14
Arista Networks
ANET
$212B
$5.84M 1.31%
363,008
+5,280
+1% +$86.2K
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$11.5B
$5.78M 1.3%
61,353
-1,164
-2% -$102K
IMPV
16
DELISTED
Imperva, Inc.
IMPV
$5.74M 1.29%
118,948
-3,866
-3% -$185K
KSU
17
DELISTED
Kansas City Southern
KSU
$5.73M 1.29%
54,092
+548
+1% +$59.6K
GRA
18
DELISTED
W.R. Grace & Co.
GRA
$5.52M 1.24%
75,265
-120
-0.2% -$8.42K
AVNT icon
19
Avient
AVNT
$3.39B
$5.37M 1.21%
124,127
+930
+0.8% +$40K
CSL icon
20
Carlisle Companies
CSL
$14B
$5.17M 1.16%
47,721
+387
+0.8% +$41K
ST icon
21
Sensata Technologies
ST
$6.55B
$5.14M 1.16%
108,120
+1,309
+1% +$68.2K
TRMB icon
22
Trimble
TRMB
$12.3B
$4.98M 1.12%
151,716
+1,332
+0.9% +$46.2K
FUL icon
23
H.B. Fuller
FUL
$3.06B
$4.89M 1.1%
91,142
+1,653
+2% +$85.8K
HOLX
24
DELISTED
Hologic
HOLX
$4.8M 1.08%
120,784
+170
+0.1% +$6.54K
MDU icon
25
MDU Resources
MDU
$4.42B
$4.71M 1.06%
432,350
-19,093
-4% -$204K
1
2 3 4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q2 2018 Portfolio in Review

As of Q2 2018, Stanley-Laman Group held 285 positions worth $445M, up 1.4% from $439M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stanley-Laman Group's Q2 2018 filing shows 23 new, 106 increased, 62 reduced and 22 closed positions. Its largest new stake was Honeywell: 21,094 shares worth $2.75M. The largest sale was KapStone Paper and Pack Corp., an estimated $4.63M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Stanley-Laman Group's largest Q2 2018 buy was Honeywell: 21,094 shares worth $2.75M.
  • Stanley-Laman Group added most to Neurocrine Biosciences in Q2 2018, an estimated $960K increase.
  • Stanley-Laman Group's biggest Q2 2018 reduction was Qualys, cutting an estimated $1.16M.
  • Stanley-Laman Group fully exited KapStone Paper and Pack Corp. in Q2 2018, selling an estimated $4.63M.
  • Stanley-Laman Group's ten largest holdings make up 17% of its $445M portfolio in Q2 2018.
  • Stanley-Laman Group opened 23 new positions and closed 22 in Q2 2018.
  • Stanley-Laman Group's portfolio value rose 1.4% quarter-over-quarter to $445M.

Based on Stanley-Laman Group's 13F filing for Q2 2018, filed 9 Aug 2018.